CTOs on the Move

Theratechnologies

www.theratech.com

 
Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.theratech.com
  • 2015 Peel Street 11th Floor
    Montreal, QC CAN H3A 1T8
  • Phone: 514.336.7800

Executives

Name Title Contact Details

Similar Companies

PMSI

PMSI is the nation's leading single-source provider of prescription medications, medical equipment and in-home medical services for the workers' compensation, chronically ill and catastrophically inju.

NewYork-Presbyterian Community Health Plan

NewYork-Presbyterian Community Health Plan is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Net

Health Net is a publicly traded managed care organization that delivers managed health care services through health plans and government-sponsored managed care plans. Its mission is to help people be healthy, secure and comfortable. Health Net provides and administers health benefits to approximately 6.0 million individuals across the country through group, individual, Medicare (including the Medicare prescription drug benefit commonly referred to as “Part D”), Medicaid, dual eligible, U.S. Department of Defense, including TRICARE, and U.S. Department of Veterans Affairs programs. Health Net also offers behavioral health, substance abuse and employee assistance programs, and managed health care products related to prescription drugs.

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.

Integrated Health Network of Wisconsin

Integrated Health Network (IHN) of Wisconsin is the state’s first multi-system, clinically integrated accountable care network and one of the first in the United States. It is a consortium of independent health systems, hospitals and physicians working together to improve the quality, efficiency and value of health care. Since its launch in 2010, IHN has been transforming health care delivery with our clinically integrated network of leading health care providers and our sophisticated infrastructure for data analytics. The result is a model that delivers high quality health care and the cost savings of a narrow network, combined with the scale and value only possible through the breadth of a larger system.